WS016, a novel potassium binder: safety, tolerability and pharmacodynamics in first-in-human phase 1 healthy volunteer study

被引：0
|
作者：
Zhang, Faming [1 ]
Song, Aiyun [1 ]
Fu, Min [1 ]
Zhou, Youcheng [1 ]
Hu, Minglong [1 ]
机构：
[1] Waterstone Pharmaceut Wuhan Co LTD, Wuhan, Peoples R China
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
2341
引用
收藏
页码：I1149 / I1151
页数：3
相关论文
共 50 条
  • [31] First-in-Human Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAR443820, a Central Nervous System Penetrant RIPK1 Inhibitor in Healthy Participants
    Hincelin-Mery, Agnes
    Lewanczyk, Pascale
    Cantalloube, Cathy
    Nicolas, Xavier
    Benamor, Myriam
    Pomponio, Robert
    Krupka, Emmanuel
    Ofengeim, Dimitry
    Eastenson, Amy
    Xiong, Li
    Atassi, Nazem
    NEUROLOGY, 2023, 100 (17)
  • [32] First-in-Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Pirepemat, a Cortical Enhancer, in Healthy Volunteers
    Rein-Hedin, Erik
    Sjoberg, Folke
    Waters, Susanna
    Sonesson, Clas
    Waters, Nicholas
    Huss, Fredrik
    Tedroff, Joakim
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (12): : 1485 - 1494
  • [33] First-in-human studies of safety, tolerability, pharmacokinetics, and pharmacodynamics of SAR443820, a centrally penetrant RIPK1 inhibitor in healthy participants
    Eastenson, Amy
    Hincelin-Mery, Agnes
    Lewanczyk, Pascale
    Cantalloube, Cathy
    Nicolas, Xavier
    Benamor, Myriam
    Pomponio, Robert
    Krupka, Emmanuel
    Ofengeim, Dimitry
    Xiong, Li
    Atassi, Nazem
    MUSCLE & NERVE, 2022, 66 : S47 - S47
  • [34] First-in-Human Phase 1 Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of DISC-0974, an Anti-Hemojuvelin Antibody, in Healthy Participants
    Novikov, Natasha
    Buch, Akshay
    Yang, Hua
    Andruk, Michelle
    Liu, Guowen
    Wu, Min
    Howell, Haley
    Macdonald, Brian
    Savage, Will
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (08): : 953 - 962
  • [35] FIRST-IN-HUMAN STUDY OF ACT-541468, A NOVEL DUAL OREXIN RECEPTOR ANTAGONIST: CHARACTERIZATION OF ITS PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY, AND TOLERABILITY
    Muehlan, C.
    Juif, P. -E.
    van Gerven, J.
    Heuberger, J.
    Dingemanse, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S80 - S80
  • [36] First-in-Human Randomized Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the KDM1A Inhibitor Vafidemstat
    Antonijoan, Rosa Maria
    Ferrero-Cafiero, Juan Manuel
    Coimbra, Jimena
    Puntes, Montse
    Martinez-Colomer, Joan
    Arevalo, Maria Isabel
    Mascaro, Cristina
    Molinero, Cesar
    Buesa, Carlos
    Maes, Tamara
    CNS DRUGS, 2021, 35 (03) : 331 - 344
  • [37] First-in-Human Randomized Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the KDM1A Inhibitor Vafidemstat
    Rosa María Antonijoan
    Juan Manuel Ferrero-Cafiero
    Jimena Coimbra
    Montse Puntes
    Joan Martínez-Colomer
    María Isabel Arévalo
    Cristina Mascaró
    Cesar Molinero
    Carlos Buesa
    Tamara Maes
    CNS Drugs, 2021, 35 : 331 - 344
  • [38] The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP3652 in First-in-Human and Ascending Multiple Oral Dose Studies in Healthy Subjects
    Masaomi Takizawa
    Dirk Cerneus
    Ingrid Michon
    Sanne Rijnders
    Desiree van der Heide
    John Meijer
    Matthias Stoelzel
    Yuichiro Sato
    Advances in Therapy, 2020, 37 : 3878 - 3900
  • [39] The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP3652 in First-in-Human and Ascending Multiple Oral Dose Studies in Healthy Subjects
    Takizawa, Masaomi
    Cerneus, Dirk
    Michon, Ingrid
    Rijnders, Sanne
    van der Heide, Desiree
    Meijer, John
    Stoelzel, Matthias
    Sato, Yuichiro
    ADVANCES IN THERAPY, 2020, 37 (09) : 3878 - 3900
  • [40] A First-In-Human Phase 1 Study to Evaluate the Safety and Tolerability of LEM-S401, a Novel siRNA-DegradaBALL Drug Targeting CTGF in Healthy Adults
    Kim, Ha-Yeon
    Cho, Jaeso
    Park, Min Kyu
    Min, Dal-Hee
    Hwang, Jun Gi
    Won, Cheolhee
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2025, 18 (04):
12345